Trials / Unknown
UnknownNCT02960126
Efficacy and Safety of Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk
Comparison of Efficacy and Safety Between Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,500 (estimated)
- Sponsor
- Chuncheon Sacred Heart Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
This study was designed in order to evaluate and compare the efficacy and safety between aspirin and clopidogrel in the patient with low stroke risk Atrial Fibrillation (AF).
Detailed description
Efficacy outcome will be evaluated the major cerebro-cardiovascular event including stroke, cardiovascular death, and myocardial infarction during 1 year-medication period. In addition, safety outcome will be evaluated the gastrointestinal responses including peptic ulcer and upper gastrointestinal bleeding events to both study drugs by repeated gastroenteroscopic examinations before and after medication by GI specialist.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aspirin | |
| DRUG | Clopidogrel |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2020-10-01
- Completion
- 2021-10-01
- First posted
- 2016-11-09
- Last updated
- 2016-11-09
Source: ClinicalTrials.gov record NCT02960126. Inclusion in this directory is not an endorsement.